PO.1.5 Scoring personalized molecular portraits identify systemic lupus erythematosus subtypesand predict transcriptional drug responses, symptomatology and disease progression

• M Petri,
• D Goldman,
• M Alarcón-Riquelme,
• D Toro Dominguez,
• P Carmona Saez,
• G Barturen,
• M Martínez Bueno,
• R López Domínguez,
• J Martorell Marugan,
• E Carnero Montoro

Affiliations

M Petri

Medicine, Division of Rheumatology, Johns Hopkins University, School of Medicine, Baltimore, USA

D Goldman

Paediatrics, Whittington Health, London, UK

M Alarcón-Riquelme

Department of Genetics and Pathology, Rudbeck Laboratory, University of Uppsala, Uppsala, Sweden

D Toro Dominguez

1GENYO, PTS, Granada, Spain

P Carmona Saez

1GENYO, PTS, Granada, Spain

G Barturen

1Centro de Genómica e Investigación Oncológica (GENYO), Pfizer-Universidad de Granada-Junta de Andalucía, Granada, Spain

M Martínez Bueno

1Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government,(GENYO), Granada, Spain

R López Domínguez

1Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government,(GENYO), Granada, Spain

J Martorell Marugan

1Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government,(GENYO), Granada, Spain

E Carnero Montoro

1Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government,(GENYO), Granada, Spain